AnorMed, AstraZeneca deal

AZN will return rights to AOM’s ZD0473, a platinum-based therapeutic to treat

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE